PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-09-02

Date Title Company
02-Sep-2021 iTeos Therapeutics to Participate in Upcoming September Investor Conferences iTeos Therapeutics
02-Sep-2021 Olink to present at two upcoming investor conferences Olink Holding AB
02-Sep-2021 Immutep completes recruitment of second-line PD-1/PD-L1 refractory NSCLC patients in TACTI-002 Immutep
02-Sep-2021 NEW PACKAGING REPORT STRENGTHENS HOLOGRAPHY ANTI-COUNTERFEITING ROLE, SAYS GLOBAL TRADE BODY IHMA
02-Sep-2021 Scientists call for 3,000 UK Long COVID sufferers of all ages, genders and ethnicities to help probe genetic link Sano Genetics
02-Sep-2021 Transgene Participates in New Cancer Research Consortium Transgene
02-Sep-2021 Prothena to Participate in Upcoming September Healthcare Conferences Prothena
02-Sep-2021 Centessa Pharmaceuticals to Present at the Morgan Stanley Virtual 19th Annual Global Healthcare Conference Centessa Pharmaceuticals
02-Sep-2021 Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment Precision BioSciences
02-Sep-2021 Takeda brinda nueva información sobre su ensayo PANTHER (Pevonedistat-3001) de fase 3 Businesswire
02-Sep-2021 Takeda informiert über den aktuellen Stand der Phase-3-Studie PANTHER (Pevonedistat-3001) Businesswire
02-Sep-2021 Takeda fornece atualização sobre Fase 3 do estudo PANTHER (Pevonedistat-3001) Businesswire
02-Sep-2021 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
02-Sep-2021 Precision BioSciences and Tiziana Life Sciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment Businesswire
02-Sep-2021 Evotec announces Bristol Myers Squibb opt-in of EVT8683 as the first programme from iPSC-based neurodegeneration collaboration Evotec SE
02-Sep-2021 Relief Reports Regulatory Clearance in Germany to Commence a Multicenter, Double-blind, Randomized Phase 2 Clinical Trial to Evaluate Inhaled Aviptadil for the Treatment of Sarcoidosis RELIEF THERAPEUTICS Holdings AG
02-Sep-2021 Riassunto: Takeda fornisce un aggiornamento sullo studio clinico PANTHER (pevonedistat-3001) di fase 3 Businesswire
02-Sep-2021 Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market Businesswire
02-Sep-2021 Dr Reddy’s Laboratories Canada annonce le lancement de Reddy-Lénalidomide, l’un des premiers médicaments génériques du genre pour le marché canadien Businesswire
02-Sep-2021 Polaryx Therapeutics Receives FDA Orphan Drug Designation for PLX-200 to Treat Krabbe Disease Newswire